123 related articles for article (PubMed ID: 12945742)
1. Roles of 5-lipoxygenase activating protein in cell proliferation and apoptosis.
Wu X; Biswal SS; Kehrer JP
Cell Biol Toxicol; 2003 Jun; 19(3):135-43. PubMed ID: 12945742
[TBL] [Abstract][Full Text] [Related]
2. A relationship between 5-lipoxygenase-activating protein and bcl-xL expression in murine pro-B lymphocytic FL5.12 cells.
Datta K; Biswal SS; Xu J; Towndrow KM; Feng X; Kehrer JP
J Biol Chem; 1998 Oct; 273(43):28163-9. PubMed ID: 9774436
[TBL] [Abstract][Full Text] [Related]
3. The 5-lipoxygenase-activating protein (FLAP) inhibitor, MK886, induces apoptosis independently of FLAP.
Datta K; Biswal SS; Kehrer JP
Biochem J; 1999 Jun; 340 ( Pt 2)(Pt 2):371-5. PubMed ID: 10333477
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid release and oxidation are factors in lipoxygenase inhibitor-induced apoptosis.
La E; Kern JC; Atarod EB; Kehrer JP
Toxicol Lett; 2003 Mar; 138(3):193-203. PubMed ID: 12565196
[TBL] [Abstract][Full Text] [Related]
5. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
Hong SH; Avis I; Vos MD; MartÃnez A; Treston AM; Mulshine JL
Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of the lipocalin 24p3 as an apoptotic mechanism for MK886.
Tong Z; Wu X; Kehrer JP
Biochem J; 2003 May; 372(Pt 1):203-10. PubMed ID: 12614196
[TBL] [Abstract][Full Text] [Related]
7. Association between bcl-x(L) and 5-lipoxygenase activating protein (FLAP) levels in IL-3-dependent FL5.12 cells.
Biswal SS; Datta K; Kehrer JP
Toxicology; 2001 Mar; 160(1-3):97-103. PubMed ID: 11246129
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of cyclo-oxygenase-2 and 5-lipoxygenase-activating protein (FLAP) expression by glucocorticoids in monocytic cells.
Goppelt-Struebe M; Schaefer D; Habenicht AJ
Br J Pharmacol; 1997 Oct; 122(4):619-24. PubMed ID: 9375956
[TBL] [Abstract][Full Text] [Related]
9. Modulation of cellular proliferation and induction of apoptosis in a human lymphoma cell line after treatment with selective lipoxygenase inhibitors.
Anderson KM; Ondrey FG; Harris JE
Adv Exp Med Biol; 1999; 469():563-8. PubMed ID: 10667383
[No Abstract] [Full Text] [Related]
10. Regulation of the expression of 5-lipoxygenase-activating protein/5-lipoxygenase and the synthesis of leukotriene B(4) in osteoarthritic chondrocytes: role of transforming growth factor beta and eicosanoids.
Martel-Pelletier J; Mineau F; Fahmi H; Laufer S; Reboul P; Boileau C; Lavigne M; Pelletier JP
Arthritis Rheum; 2004 Dec; 50(12):3925-33. PubMed ID: 15593193
[TBL] [Abstract][Full Text] [Related]
11. Glutathione oxidation and mitochondrial depolarization as mechanisms of nordihydroguaiaretic acid-induced apoptosis in lipoxygenase-deficient FL5.12 cells.
Biswal SS; Datta K; Shaw SD; Feng X; Robertson JD; Kehrer JP
Toxicol Sci; 2000 Jan; 53(1):77-83. PubMed ID: 10653524
[TBL] [Abstract][Full Text] [Related]
12. Proteolytic loss of bcl-x(L) in FL5.12 Cells undergoing apoptosis induced by MK886.
Datta K; Kern JC; Biswal SS; Kehrer JP
Toxicol Appl Pharmacol; 2001 Aug; 174(3):273-81. PubMed ID: 11485388
[TBL] [Abstract][Full Text] [Related]
13. 24R,25-(OH)(2)D(3) mediates its membrane receptor-dependent effects on protein kinase C and alkaline phosphatase via phospholipase A(2) and cyclooxygenase-1 but not cyclooxygenase-2 in growth plate chondrocytes.
Schwartz Z; Sylvia VL; Del Toro F; Hardin RR; Dean DD; Boyan BD
J Cell Physiol; 2000 Mar; 182(3):390-401. PubMed ID: 10653606
[TBL] [Abstract][Full Text] [Related]
14. Effects of the 5-lipoxygenase activating protein inhibitor MK886 on voltage-gated and Ca2+-activated K+ currents in rat arterial myocytes.
Smirnov SV; Knock GA; Aaronson PI
Br J Pharmacol; 1998 Jun; 124(3):572-8. PubMed ID: 9647483
[TBL] [Abstract][Full Text] [Related]
15. Linoleic acid peroxidation by Solanum tuberosum lipoxygenase was activated in the presence of human 5-lipoxygenase-activating protein.
Battu S; Moalic S; Rigaud M; Beneytout JL
Biochim Biophys Acta; 1998 Jun; 1392(2-3):340-50. PubMed ID: 9630716
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of vinculin upon MK886-induced apoptosis in LN18 glioblastoma cells.
Magro AM; Magro AD; Cunningham C; Miller MR
Neoplasma; 2007; 54(6):517-26. PubMed ID: 17949236
[TBL] [Abstract][Full Text] [Related]
17. Five-lipoxygenase inhibitors reduce Panc-1 survival: synergism of MK886 with gamma linolenic acid.
Harris JE; Alrefai WA; Meng J; Anderson KM
Adv Exp Med Biol; 1999; 469():505-10. PubMed ID: 10667375
[No Abstract] [Full Text] [Related]
18. 5-lipoxygenase and FLAP.
Peters-Golden M; Brock TG
Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):99-109. PubMed ID: 12895592
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of 5-lipoxygenase by MK886 augments the antitumor activity of celecoxib in human colon cancer cells.
Cianchi F; Cortesini C; Magnelli L; Fanti E; Papucci L; Schiavone N; Messerini L; Vannacci A; Capaccioli S; Perna F; Lulli M; Fabbroni V; Perigli G; Bechi P; Masini E
Mol Cancer Ther; 2006 Nov; 5(11):2716-26. PubMed ID: 17121918
[TBL] [Abstract][Full Text] [Related]
20. An experimental cell-based model for studying the cell biology and molecular pharmacology of 5-lipoxygenase-activating protein in leukotriene biosynthesis.
Gerstmeier J; Weinigel C; Barz D; Werz O; Garscha U
Biochim Biophys Acta; 2014 Sep; 1840(9):2961-9. PubMed ID: 24905297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
